XML 49 R32.htm IDEA: XBRL DOCUMENT v3.24.3
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS (Tables)
12 Months Ended
Jun. 30, 2024
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS  
Schedule of financial assets measured at fair value on a recurring basis

Fair Value Measurement of Assets as of June 30, 2024

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

61,249

$

61,249

$

$

Marketable debt securities:

Corporate commercial paper

20,929

20,929

U.S. Government agencies

1,997

1,997

U.S. Government treasuries

2,720

2,720

Corporate notes and bonds

30,832

30,832

Asset-backed securities

263

263

Total

$

117,990

$

61,249

$

56,741

$

Fair Value Measurement of Assets as of June 30, 2023

Total

Level 1

Level 2

Level 3

Cash and cash equivalents:

Money market funds

$

5,464

$

5,464

$

$

Corporate commercial paper

4,481

4,481

Marketable debt securities:

Corporate commercial paper

41,597

41,597

U.S. Government agencies

26,394

26,394

U.S. Government treasuries

10,404

10,404

Corporate notes and bonds

19,240

19,240

Asset-backed securities

4,694

4,694

Total

$

112,274

$

20,349

$

91,925

$

Schedule of changes in the fair value of the company's derivative liabilities, fair value, level 3 inputs

The following table sets forth a summary of changes in the fair value of the Company’s liabilities for which fair value was determined on a recurring basis for the fiscal years ended June 30, 2024 and 2023 (in thousands):

2024

2023

Warrant

Embedded

 

Warrant

Embedded

Fair value, beginning of fiscal year

$

$

412

$

$

407

Warrant liability incurred on March 8, 2024

5,697

Changes in fair value

2,850

56

5

Reclassification of warrant derivative liability to equity on May 13, 2024

(8,547)

Fair value, end of fiscal year

$

$

468

$

$

412